Unraveling the Significance of DGCR8 and miRNAs in Thyroid Carcinoma

Data de publicação:

Unidades de investigação

Abstract

MicroRNAs (miRNAs) act as negative regulators for protein-coding gene expression impacting cell proliferation, differentiation, and survival. These miRNAs are frequently dysregulated in cancer and constitute classes of blood-based biomarkers useful for cancer detection and prognosis definition. In thyroid cancer (TC), the miRNA biogenesis pathway plays a pivotal role in thyroid gland formation, ensuring proper follicle development and hormone production. Several alterations in the miRNA biogenesis genes are reported as a causality for miRNA dysregulation. Mutations in microprocessor component genes are linked to an increased risk of developing TC; in particular, a recurrent mutation affecting DGCR8, the E518K. In this review, we explore these novel findings and resume the current state-of-the-art in miRNAs in thyroid carcinomas.

Dados da publicação

ISSN/ISSNe:
2073-4409, 2073-4409

Cells  Multidisciplinary Digital Publishing Institute (MDPI)

Tipo:
Article
Páginas:
561-
Link para outro recurso:
www.scopus.com

Documentos

  • Não há documentos

Métricas

Filiações

Filiações não disponíveis

Keywords

  • microRNAs; thyroid cancer; DGCR8; E518K

Proyectos asociados

Selenium Clinical Supplementation In Autoimmune Thyroid Disease: A Portuguese Survey

Investigador Principal: Ana Paula Soares Dias Ferreira

Estudo Clínico Académico . 2022

Squamous cell carcinogenesis of the skin: Molecular characterization of prognostic therapeutic biomakers

Investigador Principal: Ana Paula Soares Dias Ferreira

Estudo Clínico Académico . 2022

Clinicopathological features and molecular biomarkers? role predicting papillary thyroid cancer patients? outcome: How to personalize and guide surgical treatment

Investigador Principal: Ana Paula Soares Dias Ferreira

Estudo Clínico Académico . 2022

Fatores do microambiente tumoral no cancro do ovário.

Investigador Principal: Ana Paula Soares Dias Ferreira

Estudo Clínico Académico . 2022

Citar a publicação

Partilhar a publicação